The trend towards a reduced number of exacerbations experienced by the patients of this subgroup analysis receiving tiotropium (−23%) and salmeterol (−17%) did not reach statistical significance, but the magnitude of effect resembled that observed in the original study population ( Brusasco et al 2003 ).
← all excerpts
Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.
1
—
—